References
- Abbate, V., Kicman, A.T., Evans‐Brown, M., McVeigh, J., Cowan, D.A., Wilson, C., … Walker, C.J. (2015). Anabolic steroids detected in bodybuilding dietary supplements – A significant risk to public health. Drug Testing and Analysis, 7, 609–618. doi: 10.1002/dta.1728
- AAP. (2015, August 28). Australia’s Olympic athletes banned from taking sleeping medication from time of selection, says AOC. ABC News. Retrieved from http://www.abc.net.au/news/2015-08-28/aussies-athletes-banned-from-sleeping-pills/6733600
- Assael, S., & Keating, P. (2005). Turning a blind eye to steroids. ESPN: The Magazine, 21
- Bailey, B.J. (2013). Ethnopharmacology and male bodybuilders' lived experience with consuming sports nutrition supplements in Canada. Sport in Society, 16, 1105–1119
- Baume, N., Hellemans, I., & Saugy, M. (2007). Guide to over-the-counter sports supplements for athletes. International Sports Medicine Journal, 8, 2–10
- Beamish, R., & Ritchie, I. (2004). From chivalrous ‘brothers-in-arms’ to the eligible athlete changed principles and the IOC’s banned substance list. International Review for the Sociology of Sport, 39, 355–371. doi: 10.1177/1012690204049062
- Beaudin, M. (2013, October 21). Is it medicine or dope? A cat. 4 vs. the USADA. Velo News. Retrieved from http://velonews.competitor.com/2013/10/news/is-this-man-a-doper_306150
- Birnbaum, M. (2013, March 14). Meldonium sales soar in Russia after Maria Sharapova positive test. The Guardian. Retrieved from http://www.independent.co.uk/news/world/europe/maria-sharapova-meldonium-sales-soar-in-russia-after-positive-test-a6930301.html
- Burke, M., & Symons, C. (2015). Anti-doping policies and the Gay Games; Morgan’s treatment–enhancement distinction in action. Journal of the Philosophy of Sport, 37, 1–11. doi: 10.1080/00948705.2015.1112236
- Christiansen, A.V. (2010). “We are not sportsmen, we are professionals”: Professionalism, doping and deviance in elite sport. International Journal of Sport Management and Marketing, 7, 91–103. doi: 10.1504/IJSMM.2010.029714
- Cohen, P.A., Travis, J.C., & Venhuis, B.J. (2013). A methamphetamine analog (N, a-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis, 6, 805–807. doi: 10.1002/dta.1578
- Cox, T.W. (2014). International war against doping: Limiting the collateral damage from strict liability. The Vanderbilt Journal of Transnational Law, 47, 295
- Cycling Independent Reform Commission (CIRC). (2015). Report to the president of the Union Cycliste Internationale. Retrieved from www.uci.ch/mm/Document/News/CleanSport/16/87/99/CIRCReport2015_Neutral.pdf
- Dimeo, P. (2007). A history of drug use in sport 1876–1976: Beyond good and evil. London, New York: Routledge
- Dimeo, P., & Taylor, J. (2013). Monitoring drug use in sport: The contrast between official statistics and other evidence. Drugs: Education, Prevention and Policy, 20, 40–47. doi: 10.3109/09687637.2012.713412
- Drier, F. (2015, February 9). The debate over running while high. The Wall Street Journal. Retrieved from http://www.wsj.com/articles/the-debate-over-running-while-high-1423500590
- Erickson, K., McKenna, J., & Backhouse, S.H. (2015). A qualitative analysis of the factors that protect athletes against doping in sport. Psychology of Sport and Exercise, 16, 149–155. doi: 10.1016/j.psychsport.2014.03.007
- Fretz, C. (2015a, November 19). Anti-doping is coming to masters and amateur racing. Velo News. Retrieved from http://velonews.competitor.com/2015/11/news/anti-doping-is-coming-to-masters-and-amateur-racing_389517
- Fretz, C. (2015b, November 14). USA Cycling to triple amateur anti-doping efforts. Velo News. Retrieved from http://velonews.competitor.com/2015/11/news/usa-cycling-to-triple-amateur-anti-doping-efforts_389287
- Frommer, F.J. (2009, September 29). Would-be pro player relates tale of steroid woes. Boston. Retrieved from http://www.boston.com/news/nation/washington/articles/2009/09/29/would_be_pro_player_relates_tale_of_steroid_woes/
- Gleaves, J. (2011). Doped professionals and clean amateurs: Amateurism’s influence on the modern philosophy of anti-doping. Journal of Sport History, 38, 237–254
- Gleaves, J., & Llewellyn, M. (2014). Sport, drugs and amateurism: Tracing the real cultural origins of anti-doping rules in international sport. The International Journal of the History of Sport, 31, 839–853. doi: 10.1080/09523367.2013.831838
- Hamilton, M. (2013, February 11). Marathoner’s death highlights risk of some supplements. Runner’s World. Retrieved from http://www.runnersworld.com/newswire/marathoners-death-highlights-health-risk-of-some-supplements
- Henne, K., Koh, B., & McDermott, V. (2013). Coherence of drug policy in sports: Illicit inclusions and illegal inconsistencies. Performance Enhancement & Health, 2, 48–55. doi: 10.1016/j.peh.2013.05.003
- Henning, A.D. (2013). (Self-)surveillance, anti-doping, and health in non-elite road running. Surveillance & Society, 11, 494–507
- Henning, A.D., & Dimeo, P. (2015a). The complexities of anti-doping violations: A case study of sanctioned cases in all performance levels of USA cycling. Performance Enhancement & Health, 3, 159–166. doi: 10.1016/j.peh.2015.08.001
- Henning, A.D., & Dimeo, P. (2015b). Questions of fairness and anti-doping in US cycling: The contrasting experiences of professionals and amateurs. Drugs: Education, Prevention and Policy, 22, 400–409. doi: 10.3109/09687637.2015.1029872
- Hill, K.P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA, 313, 2474–2483. doi: 10.1001/jama.2015.6199
- Hoberman, J. (2005). Testosterone dreams: Rejuvenation, aphrodisia, doping. Berkeley: University of California Press
- Houlihan, B. (1999). Dying to win: Doping in sport and the development of anti-doping policy. Strasbourg: Council of Europe Publishing
- Houlihan, B. (2004). Civil rights, doping control and the World Anti-Doping Code. Sport in Society, 7, 420–437. doi: 10.1080/1743042000291712
- Houlihan, B. (2014). Achieving compliance in international anti-doping policy: An analysis of the 2009 World Anti-Doping Code. Sport Management Review, 17, 265–276. doi: 10.1016/j.smr.2013.10.002
- Hunt, T.M. (2011). Drug games: The International Olympic Committee and the politics of doping, 1960–2008. University of Texas Press
- Johnson, J., Butryn, T., & Masucci, M.A. (2013). A focus group analysis of the US and Canadian female triathletes’ knowledge of doping. Sport in Society, 16, 654–671. doi: 10.1080/17430437.2012.753522
- Kayser, B., Mauron, A., & Miah, A. (2007). Current anti-doping policy: A critical appraisal. BMC Medical Ethics, 8, 2. doi: 10.1186/1472-6939-8-2
- Kayser, B., & Smith, A.C.T. (2008). Globalisation of anti-doping: The reverse side of the medal. British Medical Journal, 4, 337–344. doi: 10.1136/bmj.a584
- Kime, P. (2015, November 19). Jack3d, OxyElite Pro manufacturers face criminal charges. Military Times. Retrieved from http://www.militarytimes.com/story/military/2015/11/19/jack3d-oxyelite-pro-manufacturers-face-criminal-charges/76043058/
- Kisaalita, N.R., & Robinson, M.E. (2014). Attitudes and motivations of competitive cyclists regarding use of banned and legal performance enhancers. Journal of Sports Science and Medicine, 13, 44–50
- Koh, B., Edwards, J., Freeman, L., & Zaslawski, C. (2012). Doping knowledge in sports: Actus reus versus mens rea. Journal of Science and Medicine in Sport, 15, S52–S53. doi: http://dx.doi.org/10.1016/j.jsams.2012.11.127
- König, E. (1995). Criticism of doping: The nihilistic side of technological sport and the antiquated view of sport ethics. International Review for the Sociology of Sport, 30, 247–260. doi: 10.1177/101269029503000302
- Kripke, D.F. (2006). Risks of chronic hypnotic use. In Sleep and sleep disorders (pp. 141–145). US: Springer
- Küster, M., Renner, B., Oppel, P., Niederweis, U., & Brune, K. (2013). Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: A cohort study. BMJ Open, 3, e002090. doi: 10.1136/bmjopen-2012-002090
- Lentillon-Kaestner, V., Hagger, M.S., & Hardcastle, S. (2012). Health and doping in elite-level cycling. Scandinavian Journal of Medicine & Science in Sports, 22, 596–606. doi: 10.1111/j.1600-0838.2010.01281.x
- Lentillon-Kaestner, V., & Ohl, F. (2011). Can we measure accurately the prevalence of doping? Scandinavian Journal of Medicine & Science in Sports, 21, 132–142
- López, B. (2011). The invention of a ‘drug of mass destruction’: Deconstructing the EPO myth. Sport in History, 31, 84–109. doi: 10.1080/17460263.2011.555208
- López, B. (2013). Creating fear: The social construction of human Growth Hormone as a dangerous doping drug. International Review for the Sociology of Sport, 48, 220–237. doi: 10.1177/1012690211432209
- López, B. (2014). Creating fear: The ‘doping deaths’, risk communication and the anti-doping campaign. International Journal of Sport Policy and Politics, 6, 213–225. doi: 10.1080/19406940.2013.773359
- McNamee, M.J. (2012). The spirit of sport and the medicalization of anti-doping: Empirical and normative ethics. Asian Bioethics Review, 4, 374–392
- McNamee, M.J. (2013). The spirit of sport and anti-doping policy: An ideal worth fighting for. Play True (Montreal: World anti-Doping Agency), 1, 14–16
- McNamee, M.J., & Tarasti, L. (2010). Juridical and ethical peculiarities in doping policy. Journal of Medical Ethics, 36, 165–169. doi: 10.1136/jme.2009.030023
- Melia, P., Pipe, A., & Greenberg, L. (1996). Condemning and condoning: Elite amateurThe use of anabolic-androgenic steroids by Canadian students. Clinical Journal of Sport Medicine, 6, 9–14
- Møller, V. (2004). The anti-doping campaign* – Fairwell to the ideals of modernity. In Hoberman, J.M., & Møller, V. (Eds.), Doping and public policy (pp. 145–159). Odense: University Press of Southern Denmark
- Møller, V. (2010). The ethics of doping and anti-doping: Redeeming the soul of sport? London: Routledge
- NSF. (2016). About NSF. Retrieved from http://www.nsf.org/about-nsf
- Outram, S.M., & Stewart, B. (2015). Condemning and condoning: Elite amateur cyclists’ perspectives on drug use and professional cycling. International Journal of Drug Policy, 26, 682–687. doi: 10.1016/j.drugpo.2015.01.007
- Overbye, M., & Wagner, U. (2013). Between medical treatment and performance enhancement: An investigation of how elite athletes experience: Therapeutic use exemptions. International Journal of Drug Policy, 24, 579–588. doi: 10.1016/j.drugpo.2013.03.007
- Petróczi, A., & Aidman, E. (2008). Psychological drivers in doping: The life-cycle model of performance enhancement. Substance Abuse Treatment, Prevention, and Policy, 3, 1–12. doi: 10.1186/1747-597X-3-7
- Pitsch, W., Emrich, E., & Klein, M. (2007). Doping in elite sports in Germany: Results of a www survey. European Journal for Sport and Society, 4, 89–102. doi: 10.1080/16138171.2007.11687797
- Pluim, B. (2008). A doping sinner is not always a cheat. British Journal of Sports Medicine, 42, 549–550
- Ramachandra, K., Narendranat, S., Somashekar, H.S., Patil, N.A., Reshma, S.R., & Veena, A. (2012). Drug abuse in sports. Journal of Pharmacy Research, 5, 593–603
- Ritchie, I. (2014). Pierre de Coubertin, doped ‘amateurs’ and the ‘spirit of sport’: The role of mythology in Olympic anti-doping rules. The International Journal of the History of Sport, 31, 820–838. doi: 10.1080/09523367.2014.883500
- Running USA. (2013). 2013 State of the sport – Part I: “Core Runner”. Retrieved from http://www.runningusa.org/index.cfm?fuseaction=news.details&ArticleId=1539&returnTo=annual-reports
- Scott, S., Branley, A., & Bembridge, C. (2016, February 13). Man given two weeks to live after taking popular weight-loss product purchased online. ABC News. Retrieved from http://www.abc.net.au/news/2016-02-14/man-faced-death-after-taking-popular-weight-loss-product/7162378
- Soukup-Baljak, Y., Greer, A.M., Amlani, A., Sampson, O., & Buxton, J.A. (2015). Drug quality assessment practices and communication of drug alerts among people who use drugs. The International Journal of Drug Policy, 26, 1251–1257. doi: 10.1016/j.drugpo.2015.06.006
- Stewart, B., & Smith, A.C. (2008). Drug use in sport implications for public policy. Journal of Sport & Social Issues, 32, 278–298. doi: 10.1177/0193723508319716
- Strelan, P., & Boeckmann, R.J. (2006). Why drug testing in elite sport does not work: Perceptual deterrence theory and the role of personal moral beliefs. Journal of Applied Social Psychology, 36, 2909–2934.doi: 10.1111/j.0021-9029.2006.00135.x
- Tandon, S., Bowers, L.D., & Fedoruk, M.N. (2015). Treating the elite athlete: Anti-doping information for the health professional. Missouri Medicine, 112, 122–128
- Teetzel, S., & Weaving, C. (2013). From silence to surveillance: Examining the aftermath of a Canadian university doping scandal. Surveillance & Society, 11, 481–493
- Tokish, J.M., Kocher, M.S., & Hawkins, R.J. (2004). Ergogenic aids: A review of basic science, performance, side effects, and status in sports. The American Journal of Sports Medicine, 32, 1543–1553. doi: 10.1177/0363546504268041
- United States Anti-Doping Agency (USADA). (2015). Therapeutic Use Exemption Policy. Retrieved from http://www.usada.org/substances/tue/policy/
- Venhuis, B., Keizers, P., Riel, A., & Kaste, D. (2014). A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events. Drug Testing and Analysis, 6, 578–581. doi: 10.1002/dta.1664
- World Anti-Doping Agency (WADA). (2015). World Anti-Doping Code. Retrieved from https://www.wada-ama.org/en/resources/the-code/world-anti-doping-code
- World Anti-Doping Agency (WADA). (2016). Prohibited List. Retrieved from https://wada-main-prod.s3.amazonaws.com/resources/files/wada-2016-prohibited-list-en.pdf
- Waddington, I. (Drug use in sport implications for public policy (2001). Doping in sport: Some issues for medical practitioners. Cited in Stewart, B., & Smith, A. C. (2008). Journal of Sport & Social Issues, 32, 278–298. doi: 10.1177/0193723508319716
- Waddington, I., Christiansen, A.V., Gleaves, J., Hoberman, J., & Møller, V. (2013). Recreational drug use and sport: Time for a WADA rethink? Performance Enhancement & Health, 2, 41–47. doi: 10.1016/j.peh.2013.04.003
- Young, A. (2013, September 27). Sports supplement designer has history or risky products. USA Today. Retrieved from http://www.usatoday.com/story/news/nation/2013/07/25/bodybuilding-supplement-designer-matt-cahill-usa-today-investigation/2568815/